Other
AOCI - Cash Flow Hedge Reclassification (Next 12 Months)
Merck & Co. AOCI - Cash Flow Hedge Reclassification (Next 12 Months) increased by 40.3% to -$178.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 167.9%, from $262.00M to -$178.00M. Over 2 years (FY 2023 to FY 2025), AOCI - Cash Flow Hedge Reclassification (Next 12 Months) shows a downward trend with a 111.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ3 2018
Last reportedQ3 2025
How to read this metric
Provides visibility into future earnings volatility related to existing hedge contracts.
Detailed definition
This represents the portion of gains or losses on cash flow hedges currently held in Accumulated Other Comprehensive Inc...
Peer comparison
Standard disclosure for companies using hedge accounting under ASC 815.
Metric ID:
aoci_cash_flow_hedge_reclassification_12mHistorical Data
10 periods
| Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $269.00M | -$40.00M | $113.00M | $190.00M | -$161.00M | $262.00M | $16.00M | -$473.00M | -$298.00M | -$178.00M |
| QoQ Change | — | -114.9% | +382.5% | +68.1% | -184.7% | +262.7% | -93.9% | <-999% | +37.0% | +40.3% |
| YoY Change | — | — | — | — | -159.9% | +755.0% | -85.8% | -348.9% | -85.1% | -167.9% |
Range-$473.00M – $269.00M
CAGR-16.8%
Avg YoY Growth-15.4%
Median YoY Growth-122.8%
Current Streak2 quarters growth
AOCI - Cash Flow Hedge Reclassification (Next 12 Months) at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s aoci - cash flow hedge reclassification (next 12 months)?
- Merck & Co. (MRK) reported aoci - cash flow hedge reclassification (next 12 months) of -$178.00M in Q4 2025.
- How has Merck & Co.'s aoci - cash flow hedge reclassification (next 12 months) changed year-over-year?
- Merck & Co.'s aoci - cash flow hedge reclassification (next 12 months) decreased by 167.9% year-over-year, from $262.00M to -$178.00M.
- What is the long-term trend for Merck & Co.'s aoci - cash flow hedge reclassification (next 12 months)?
- Over 2 years (2023 to 2025), Merck & Co.'s aoci - cash flow hedge reclassification (next 12 months) has grown at a 111.0% compound annual growth rate (CAGR), from -$40.00M to -$178.00M.
- What does aoci - cash flow hedge reclassification (next 12 months) mean?
- The amount of hedge gains or losses expected to hit the income statement over the next 12 months.